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Genetic and epigenetic changes are at the center of cancer development. Breast 25 cancer molecular subtypes are defined on differences in genetic and epigenetic 26 profiles and it is generally assumed these subtypes originate from different cell 27 lineages in the mammary gland. We propose that founding oncogenic mutations could 28 also have an impact. To address this question, we designed an experimental model, 
6
In addition to structural defects, cancer genomes undergo important epigenetic 7 changes occurring at the chromatin and DNA levels [3] . At the DNA level, cancer 8 associated epigenetic modifications involve genome wide cytosine methylation 9 changes corresponding to demethylation of repetitive DNA sequences and 10 hypermethylation of CpG enriched sequences. While demethylation of repetitive DNA 11 has been proposed to favor chromosomal instability, hypermethylation of CpG rich 12 promoter sequences has been associated with gene expression changes [4, 5] .
13
Genetic instability results in stochastically occurring aberrations, of which a fraction 14 will be selected according to the survival or growth advantage they confer to the cells.
15
Hence, profiles of somatically acquired genetic and epigenetic changes and associated 
25
In breast cancer, molecular subtypes were defined on the basis of RNA expression, as 26 well as of genomic anomalies and DNA methylation differences [8] [9] [10] [11] . Although 27 definitive proof is still missing, it is generally proposed that the genetic and epigenetic 28 differences in different breast tumor subtypes are dictated by distinct cell types of 29 origin [8, 9] . Early activation of distinct oncogenic pathways in a single cell type could 30 also have an impact on genomic and epigenetic changes and induce the selection of 31 anomalies functionally coherent with the activated pathway [12] [13] [14] [15] . This is supported [16, 17] . Yet, it has not been experimentally demonstrated that distinct oncogenic events could lead to specific 1 genomic rearrangements.
2
In this work, we sought to determine the impact of the early activation of distinct 3 oncogenic pathways on genomic and epigenetic changes in immortalized human 
14
after infection. We derived three stable shp53 HMEC sublines, which we will refer to as
15
R2
shp53 and used as models in this work. 
27
CCNE1.SA (Fig 3A) . The distance along the PC1 vector in the principal component 28 analysis, separating cluster 2 from cluster 3, illustrated the strong differences at the
29
CNA level between the RAS and the WNT1 or CCNE1 transformed sublines (Fig 3A) .
30
A (Fig 1D) . In 6 contrast, R2 shp53-RAS HMECs did not show significant changes in CNAs after soft agar 7 cloning (Fig 1D and Fig 3B) . 
27
17q21 or 20q11-q13, losses at 6q) (S1 Table) . We also noted that 78 genes, gained significantly lower incidence of CNAs than the Basal-like/Non-Claudin-low (Fig 7B-C) 
21
and that the KRAS pathway was among the top activated pathways in the Claudin- 
26
The latter two exhibited globally similar CNA and DNA methylation profiles, albeit 27 some focal differences could be found.
28
In our model system, inactivation of the TP53 gene was the initial step towards 
The nature of the genes whose expression was modified either by DNA methylation or
29
CNAs were consistent with the dominant pathways activated and reflected the 30 phenotypes in the respective models, mesenchymal in R2 shp53-RAS , epithelial in R2
shp53-
31
CCNE1 /R2 shp53-WNT1 (Fig 8) .
32
Thus, our data strongly suggest that early activation of distinct oncogenic insults in a
33
given cell type will not only impinge on the phenotypic characteristics of the resulting 34 tumors, but also impact on their genomic and epigenetic landscapes and could 
Material and Methods
17
Labeling products were precipitated with isopropanol and resuspended in water. Test 
26
Normalized files were used as input for the Nexus 6. 
12
We used consensus PCA from the MoGSA R package and displayed the results from 
27
High throughput data analysis
28
Detailed methods are presented in the Supplementary Methods. Raw array and RRBS 29 data can be accessed at GSE114849 (see S Appendix).
30
Figure Legend: 31 32 
13
Non supervised hierarchical clustering (Ward) on PC1 and PC2 segregating in three
14
clusters (red line threshold). 
30
The hight of the bars indicates the amplitude of the copy number change. 
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